Delivery Order SPE2DB22D1106-SPE2DB25FEPM4
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,732,286 units of Cyclophosphamide 2 GM vials, a chemotherapy drug. The $70,284.14 firm-fixed-price contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,735.80 contract is for the delivery of Cyclophosphamide 500 mg vials, a critical pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cyclophosphamide 500 mg/2.5 ml vials. The $1,557.60 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of November 29, 2024. The contract was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,906.40, is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a specialty medication. The contract has an ultimate completion date of June 24, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclophosphamide 2 GM/10 ML VL 10ML, a medical product, with a ceiling value of $3,139.38 and a period of performance through May 7, 2025. The contract is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,731.28, is for the delivery of Cyclophosphamide 1 GM/5 ML VL 5ML, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 26, 2025. This contract is not designated with a set-aside requirement, indicating open...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of 4,563,881,075 units of Cyclophosphamide 500 mg vials with a potential value of $2,158.88. The contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,553.88, is for the delivery of 4,568,075,876 units of the drug Cyclophosphamide 500 mg vials. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $10,879.61 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to supply 4,559,091,492 units of the pharmaceutical product Cyclophosphamide 1 GM Vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 through December 2025, for delivering a comprehensive range of...
This federal contract award is for the delivery of Cyclophosphamide 2 GM vials to the Defense Logistics Agency (DLA). The $9,120.41 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a performance period ending on December 9, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...